AstraZeneca has signed a cooperation agreement with China's Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday.
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021.
Rachel Wisniewskihas signed a cooperation agreement with China's Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday., will be responsible for the import and distribution of Evusheld in mainland China once the drug is approved to enter the Chinese market with conditions or for emergency use.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WHO working with China on Lunar New Year COVID risksThe World Health Organization said it is working with China to manage the risks of COVID-19 surging again as people travel for Lunar New Year celebrations but the country's response continues to be challenged by a lack of data.
Consulte Mais informação »
China's authorities are quietly rounding up people who protested against COVID rulesChinese authorities are quietly rounding up people who protested COVID rules and attended vigils for those who died in lockdown.
Consulte Mais informação »
Countries ponder wider wastewater testing amid hope airports offer China COVID cluesAn international meeting this week will discuss setting up a global system of wastewater monitoring for COVID.
Consulte Mais informação »
China, engulfed in covid chaos, braces for Lunar New Year case spikeHundreds of millions of people will travel for Lunar New Year after the “zero covid” policy ended, testing China's already stretched health-care system.
Consulte Mais informação »